1h Free Analyst Time
The poc molecular diagnostics market is forecasted to grow by USD 1.14 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the poc molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increase in adoption of microarrays in genomics and proteomics, and increased focus on personalized medicine.
The poc molecular diagnostics market is segmented as below:
By Product
- PCR
- Microarray and hybridization
By Application
- Infectious diseases
- Oncology
- Hematology and endocrinology
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the poc molecular diagnostics market covers the following areas:
- Poc molecular diagnostics market sizing
- Poc molecular diagnostics market forecast
- Poc molecular diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global poc molecular diagnostics market: Abbott Laboratories, Becton Dickinson and Co., binx health inc., bioMerieux SA, Co Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., genedrive plc, Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., Pfizer Inc., QIAGEN NV, QuantuMDx Group Ltd., Quidelortho Corp., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing focus on technological advances."
According to the report, one of the major drivers for this market is the growing geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton Dickinson and Co.
- binx health inc.
- bioMerieux SA
- Co Diagnostics Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- genedrive plc
- Molbio Diagnostics Pvt. Ltd.
- OraSure Technologies Inc.
- Pfizer Inc.
- QIAGEN NV
- QuantuMDx Group Ltd.
- Quidelortho Corp.
- Randox Laboratories Ltd.
- Robert Bosch GmbH
- Siemens AG
- Sysmex Corp.
- Talis Biomedical Corp
- Thermo Fisher Scientific Inc.
